POLYMORPHISMS OF N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASE MU AND THETA GENES AS RISK FACTORS OF BLADDER CANCER IN RELATION TO ASTHMA AND TUBERCULOSIS
- 1 July 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 164 (1), 209-213
- https://doi.org/10.1016/s0022-5347(05)67496-4
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- SHORT COMMUNICATION: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancersCarcinogenesis: Integrative Cancer Research, 1996
- Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectThe Lancet, 1996
- Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphismBiochemical Journal, 1994
- Acetylator Phenotype, Aminobiphenyl-Hemoglobin Adduct Levels, and Bladder Cancer Risk in White, Black, and Asian Men in Los Angeles, CaliforniaJNCI Journal of the National Cancer Institute, 1994
- Drug-metabolizing enzymes in ligand-modulated transcriptionBiochemical Pharmacology, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993
- An improved method for genotyping ofN-acetyltransferase polymorphism by polymerase chain reactionJournal of Human Genetics, 1993
- A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studiesNucleic Acids Research, 1991
- A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancerCarcinogenesis: Integrative Cancer Research, 1986
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982